Table 2

Costs and Outcomes of Integrated Human African Trypanosomiasis Surveillance System Using Rapid Diagnostic Tests, Democratic Republic of the Congo

Rian Snijders

, Alain Fukinsia, Yves Claeys, Epco Hasker, Alain Mpanya, Erick Miaka, Filip Meheus, and Marleen Boelaert¹

Author affiliations: Swiss Tropical and Public Health Institute, Basel, Switzerland (R. Snijders); University of Basel, Basel (R. Snijders); Institute of Tropical Medicine, Antwerp, Belgium (R. Snijders, Y. Claeys, E. Hasker, M. Boelaert); Programme National de Lutte contre la Trypanosomiase Humaine Africaine, Kinshasa, Democratic Republic of the Congo (A. Fukinsia, A. Mpanya, E. Miaka); International Agency for Research on Cancer, Lyon, France (F. Meheus)

Main Article

Annual economic costs of passive human African trypanosomiasis screening in Mosango and Yasa Bonga health districts, Democratic Republic of the Congo*

Cost category and subcategory	Description	Cost, USD			Total, %
Cost category and subcategory	Description	Mosango	Yasa Bonga	Total	Total, %
Capital equipment		18,008	25,051	43,060	25
Equipment	Confirmation equipment	4,734	6,627	11,360	7
	Laboratory equipment	2,539	3,554	6,093	4
	Nonmedical equipment	2,195	3,073	5,268	3
Training	HAT diagnosis training	13,275	18,424	31.699	19
	Screening	5,079	6,950	12,029	7
	Microscopy	8,196	11,474	19,670	12
Annual recurrent costs		69,243	56,764	126,008	75
Laboratory and medical supplies	HAT tests	7,487	5,449	12,262	7
	RDTs	7,388	4,874	12,262	7
	Microscopy	99	575	673	0.4
Patient care	Staging and inpatient and outpatient care	413	1,601	2,014	1
HR and infrastructure use	Execution RDT	36,535	24,102	60,637	36
Management	Management and supervision	24,808	25,613	50,421	30
Total		87,251	81,816	169,067	100
Cost per person screened		7.95	11.29	9.28
Cost per case diagnosed and treated		21,813	3,557	6,262

*HAT, human African trypanosomiasis; HR, human resources; RDT, rapid diagnostic test.

Main Article

¹Deceased.

Page created: June 10, 2021

Page updated: July 18, 2021

Page reviewed: July 18, 2021

The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.